Stock CIM CHIMERA INVESTMENT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Chimera Investment Corporation

Equities

CIM

US16934Q2084

Real-time Estimate Cboe BZX
Other stock markets
 01:05:44 2024-04-19 pm EDT 		5-day change 1st Jan Change
4.105 USD +2.11% Intraday chart for Chimera Investment Corporation +0.37% -17.94%
Mar. 13 IPOs: 2024 should be a vintage year Our Logo
Mar. 08 UBS Downgrades Chimera Investment to Neutral From Buy, $5 Price Target MT

Evolution of the average Target Price on Chimera Investment Corporation

Price target over the last 5 years

History of analyst recommendation changes

17d7960ccc20ad30a8fb438.tgWsqPdU_59jGE8a1uq516NkSPJ0UQPiDfffGsHp8mA.7mTA8rMMlfIpWn1Sl4jQgPsLF4AOIEKwdYORc5GcihTgdsbJrzaZ3RZeFg~4e912044af3035edc7398d6c6c8b0bbf

Analyst Recommendations on Chimera Investment Corporation

UBS Downgrades Chimera Investment to Neutral From Buy, $5 Price Target MT
UBS Initiates Coverage on Chimera Investment With Neutral Rating, $5.50 Price Target MT
Credit Suisse Trims Chimera Investment's PT to $5.50 From $6.50 on Reduced Earnings Power, Expectations for Reduction in Dividend; Keeps Neutral Rating MT
RBC Cuts Price Target on Chimera Investment to $6 From $7, Maintains Outperform Rating MT
Keefe, Bruyette & Woods Adjusts Price Target on Chimera Investment to $6.25 From $7, Maintains Market Perform Rating MT
RBC Cuts Price Target on Chimera Investment to $7 From $11, Noting Unexpected Dividend Cut, Maintains Outperform Rating MT
Barclays Adjusts Price Target on Chimera Investment to $9 From $11, Reiterates Underweight Rating MT
RBC Cuts Price Target on Chimera Investment to $11 From $15, Maintains Outperform Rating MT
Barclays Adjusts Chimera Investment's Price Target to $11 from $14, Keeps Underweight Rating MT
RBC Boosts Price Target on Chimera Investment to $18 From $16, Maintains Outperform Rating MT
CHIMERA INVESTMENT : RBC Raises Price Target on Chimera Investment to $16 From $14, Maintains Outperform Rating MT
CHIMERA INVESTMENT : RBC Boosts Price Target on Chimera Investment to $14 From $12.50, Maintains Outperform Rating MT
CHIMERA INVESTMENT : RBC Capital Adjusts Chimera Investment's Price Target to $12.50 From $11, Maintains Outperform Rating MT
CHIMERA INVESTMENT : Barclays Downgrades Chimera Investment to Underweight From Equal Weight; Trims PT to $10 From $11 MT
CHIMERA INVESTMENT : BTIG Starts Chimera Investment at Neutral MT
CHIMERA INVESTMENT : RBC Capital Adjusts Chimera Investment's Price Target to $11 From $10, Maintains Outperform Rating MT
Chimera Investment Corporation(NYSE:CIM.PRA) added to S&P U.S. Fixed Rate Preferred Stock Index CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
4.02 USD
Average target price
4.875 USD
Spread / Average Target
+21.27%
High Price Target
5 USD
Spread / Highest target
+24.38%
Low Price Target
4.75 USD
Spread / Lowest Target
+18.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Chimera Investment Corporation

UBS
Credit Suisse
RBC Capital Markets
Keefe, Bruyette & Woods
Barclays

Ratings for Chimera Investment Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CIM Stock
  4. Consensus Chimera Investment Corporation